1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
January 5, 1996
- --------------------------------------------------------------------------------
Date of Report (Date of earliest event reported)
Response Oncology, Inc.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in charter)
Tennessee 0-15416 62-1212264
- --------------------------------------------------------------------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
1775 Moriah Woods Blvd.
Memphis, Tennessee 38117
- --------------------------------------------------------------------------------
(Address of principal executive offices)
(901) 761-7000
- --------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
Response Technologies, Inc.
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
2
ITEM 5: OTHER EVENTS
Reference press release attached as Exhibit 99.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be filed on its behalf
by the undersigned thereunto duly authorized.
Dated: January 5, 1996
Response Oncology, Inc.
By: /s/ Daryl P. Johnson
--------------------
Daryl P. Johnson
Vice President and
Chief Financial Officer